Free Trial

GoodRx (GDRX) Earnings Date, Estimates & Call Transcripts

GoodRx logo
$3.97 +0.02 (+0.51%)
Closing price 05/20/2025 04:00 PM Eastern
Extended Trading
$3.95 -0.02 (-0.48%)
As of 08:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GoodRx Earnings Summary

GoodRx issued Q1 2025 earnings on May 7, 2025, reporting an EPS of $0.09, which topped the consensus estimate of $0.04 by $0.05. Quarterly revenue rose 2.6% year-over-year to $202.97 million, above analysts' expectations of $202.25 million. With a trailing EPS of $0.08, GoodRx's earnings are expected to grow 38.46% next year, from $0.13 to $0.18 per share.

Latest Q1
Earnings Date
May. 7Estimated
Consensus EPS
(May. 7)
$0.04
Actual EPS
(May. 7)
$0.09 Beat By $0.05
Actual Revenue
(May. 7)
$202.97M

Q1 2025 Earnings Resources

Get GoodRx Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GoodRx and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GDRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GDRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

GoodRx Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20251$0.05$0.05$0.05$202.6 M$201.0 M - $205.0 M
Q2 20251$0.06$0.06$0.06$206.3 M$203.0 M -
Q3 20251$0.06$0.06$0.06
Q4 20251$0.06$0.06$0.06

GoodRx Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025$0.04$0.09+$0.05$0.03$202.25M$202.97M
8/8/2024Q2 2024$0.09$0.08 -$0.01$0.02$200.47M$200.60M
5/9/2024Q1 2024$0.04$0.03 -$0.01$0.06$196.20M$197.88M
2/29/2024Q4 2023$0.02$0.02-$0.10$195.59M$196.64M
11/9/2023Q3 2023$0.06$0.06-$0.09$188.52M$180.00M
8/9/2023Q2 2023$0.01$0.02+$0.01-$0.10$186.90M$189.68M

GoodRx Earnings - Frequently Asked Questions

GoodRx (NASDAQ:GDRX) last announced its quarterly earning data on Wednesday, May 7, 2025. Learn more on GDRX's earnings history.

GoodRx issued an update on its second quarter 2025 earnings guidance on Wednesday, May, 7th. The company issued revenue guidance of $203.0 million-, compared to the consensus revenue estimate of $206.3 million.

In the previous quarter, GoodRx (NASDAQ:GDRX) reported $0.09 earnings per share (EPS) to beat the analysts' consensus estimate of $0.04 by $0.05. Learn more on analysts' earnings estimate vs. GDRX's actual earnings.

The conference call for GoodRx's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for GoodRx's latest earnings report can be read online.
Read Transcript

GoodRx (NASDAQ:GDRX) has a recorded annual revenue of $797.41 million.

GoodRx (NASDAQ:GDRX) has a recorded net income of -$8.87 million. GDRX has generated $0.08 earnings per share over the last four quarters.

GoodRx (NASDAQ:GDRX) has a forward price-to-earnings ratio of 30.54. The price/earnings-to-growth ratio is 2.46.

GoodRx's earnings are expected to grow from $0.13 per share to $0.18 per share in the next year, which is a 38.46% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:GDRX) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners